Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5275746
Max Phase: Preclinical
Molecular Formula: C39H65N11O10S
Molecular Weight: 880.08
Associated Items:
ID: ALA5275746
Max Phase: Preclinical
Molecular Formula: C39H65N11O10S
Molecular Weight: 880.08
Associated Items:
Canonical SMILES: C/C=C1/NC(=O)C(NC(=O)CNC(=O)CCCCCCCCCCCCNC(=N)N)CC2(CSCC(C(=O)O)NC(=O)CNC(=O)CNC2=O)NC(=O)[C@H]([C@@H](C)CC)NC1=O
Standard InChI: InChI=1S/C39H65N11O10S/c1-4-24(3)32-35(57)50-39(23-61-22-27(36(58)59)47-31(54)21-44-29(52)19-45-37(39)60)18-26(34(56)48-25(5-2)33(55)49-32)46-30(53)20-43-28(51)16-14-12-10-8-6-7-9-11-13-15-17-42-38(40)41/h5,24,26-27,32H,4,6-23H2,1-3H3,(H,43,51)(H,44,52)(H,45,60)(H,46,53)(H,47,54)(H,48,56)(H,49,55)(H,50,57)(H,58,59)(H4,40,41,42)/b25-5+/t24-,26?,27?,32-,39?/m0/s1
Standard InChI Key: JLDAJDICEQWWPK-BCPKHNOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 880.08 | Molecular Weight (Monoisotopic): 879.4637 | AlogP: -1.28 | #Rotatable Bonds: 19 |
Polar Surface Area: 332.00 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.41 | CX Basic pKa: 12.23 | CX LogP: -3.67 | CX LogD: -3.67 |
Aromatic Rings: 0 | Heavy Atoms: 61 | QED Weighted: 0.03 | Np Likeness Score: 0.57 |
1. Ijichi S, Hoshino S, Asamizu S, Onaka H.. (2023) SolS-catalyzed sulfoxidation of labionin to solabionin drives antibacterial activity of solabiomycins., 89 [PMID:37169227] [10.1016/j.bmcl.2023.129323] |
Source(1):